BioInvent International has announced a clinical trial collaboration and supply agreement with MSD International Business for a Phase 1/2a study of its monoclonal antibody BI-1910 in combination with KEYTRUDA. Under
NOT A SUBSCRIBER? SIGN UP TODAY AND GET THE FULL LIFE SCIENCE PICTURE
ONLY 13 €/MONTH
NLS News
The two companies have entered into a definitive agreement for Genmab to acquire ProfoundBio in an all-cash transaction. Genmab will acquire ProfoundBio for USD 1.8 billion in cash, payable at
The two companies have announced a collaboration to commercialize Oncopeptides’ drug Pepaxti in the Middle East and North Africa countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia,
The company has entered into a collaboration with a research group at University of Glasgow, UK, with the objective of performing an exploratory phase 2 study with rabeximod in patients
Taking the temperature of 2024 investment climate at Nordic American Healthcare Conference (NAHC), NYC. The recent years have been a bit of a roller-coaster for the life science industry’s confidence.
The two companies will develop digital patient monitoring for people with advanced renal cell carcinoma (RCC), using Elekta’s Kaiku Health solution, a digital platform for patient engagement and reported outcomes
InDex Pharmaceuticals has announced that its CEO Jenny Sundqvist and its CFO & Deputy CEO Johan Giléus will leave the company per September 26, 2024. Jenny Sundqvist and Johan Giléus
On Friday 9th of February, Oslo Science Park buzzed with life. A large crowd was present when the two ministers for health and trade announced the government’s fifteen point export
Braincool announces that it is reporting its former CEO to the police over a prohibited loan, and that it will have to raise capital of SEK 85-95 million. The police
A SEK 7.7 million investment is being made into the BRIDGE Sweden project, designed to streamline the journey from research to commercialization of biological pharmaceuticals and precision medicine. Running for
The company has received SEK 5 million from Eurostars in a collaborative project with the French biotech company Okomera. The funding is intended to strengthen the development of an analysis
Novo Nordisk has agreed to acquire Cardior for up to EUR 1.025 billion, including an upfront payment and additional payments if certain development and commercial milestones are achieved. Cardior is
The company has been awarded up to EUR 10 million in grant and equity financing by the European Innovation Council (EIC) Accelerator program to support the company through key milestones
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing authorization for Awiqli (the brand name for once-weekly basal insulin icodec)
Sponsored content
Cell and Gene Therapy Developers: This Is What Your Logistics Provider Must Do
In this article, John Coleman, Business Unit Director at ATMP logistics provider YSDS Life Science, explores the crucial role of logistics providers in ensuring the seamless transport of ATMPs in while adhering to the standards for an optimal vein-to-vein process.
Affibody has announced that the first patients have been dosed in a clinical basket study of the PET imaging agent 68Ga-ABY-025 for non-invasive quantification of HER2-status in solid tumors. ABY-025
Sobi has announced results from the AVA-PED-301 study, evaluating the efficacy and safety of avatrombopag (Doptelet) for the treatment of paediatric patients with immune thrombocytopenia (ITP) of at least 6
Careers
Isa Lindgren has been intrigued by all things science since she was a child. As Manager of Analytical Development at NorthX Biologics she gets to integrate her fascination with a
SwedenBIO has appointed the co-founder and operational manager of Sprint Bioscience, Jessica Martinsson, as its new Director General. “With her entrepreneurial experience and co-founder of a life science company, SwedenBIO
Evaxion Biotech has announced that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd. “With Per at the steering wheel, we expect to bring
Careers
Being part of a fast-paced industry where the technology is constantly evolving is part of what makes life science law an enjoyable challenge, said Attorney Hanna Paloheimo, who oversees the life sciences division at Castrén & Snellman Attorneys of Helsinki.
JOB ALERTS
Read the latest issue of our magazine!
No 01 2024 // Many scientists state that we are entering the golden age of CNS disease treatment. Learn more about some of the most recent progress being made within the field, including Nordic advances. This issue’s profile is professor Mia Phillipson, co-founder of Ilya Pharma, co-director at SciLifeLab, a member of the Royal Swedish Academy of Sciences, and a scientist pioneering immunotherapies. We have a special report on the life science financial landscape, including VC predictions for 2024, an interview with Thomas Eldered, Flerie Invest, and a global outlook. This issue also includes a special focus on the skills shortages within cell and gene therapy manufacturing, startup advice and what it is like to work as a Bioprocess Engineer.
The latest research news from the Nordic region
Science articles
The Royal Institute of Art and SciLifeLab have connected the creative minds of artists and scientists and the outcome of this fusion is explored in an exhibition at SciLifeLab campus.
Henrik Toft Sørensen, Professor of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, is receiving the 2023 prize, accompanied by 1.5 million DKK. He receives the Prize in recognition of
Findings from the major study iStopMM has been used to redefine monoclonal gammopathy of undetermined significance (MGUS), a precursor to multiple myeloma. We spoke with Þórir Einarsson Long, one of
An international team of researchers have combined ideas from biology, computer science and mathematics to explain why evolution seems to favor symmetry. We spoke with Iain Johnston, a professor at
Thanks to a donation of SEK 35 million from financier and philanthropist Rune Andersson, Karolinska Institutet’s research group leader Andrea Carmine Belin will very soon be setting up the world’s
Olink Holding has announced the 2022 winner of the young researchers’ award, Novelties in Biomarkers, Maria Martin-Grau at the University of Valencia, Spain. Novelties in Biomarkers is an annual award
Nordic Life Science
The latest clinical trials
Sign up to our newsletter